In subjects with baseline viral load 100,000 copies/mL , resistance development was low ( < 2 % ) for both RPV/FTC/TDF and EFV/FTC/TDF arms and less frequent compared with subjects with baseline viral load > 100,000 copies/mL , for RPV/FTC/TDF .